NEWARK, Del, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global fructosamine test market was valued at around US$ 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period.

Please provide your email address to receive an email when new articles are posted on . Fructosamine can be a good glycemia screening tool and elevated levels can have a predictive role for ...

Using a different marker to track a patient's glycemic levels could help improve outcomes after surgery for diabetic and non-diabetic patients alike. Researchers identified a new way to lower the risk ...

The global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total market valuation is expected ...